Need Help? Call 1­-866-­796-­7386
« back to stock screener

  AVIR stock: Aviragen Therapeutics Inc

Current Rating
Sell

Previous Rating:

Strong Buy
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$1.32
Market Cap
54.5M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
1.48
P/S
7.12
Dividend %
-
P/CF
90.3
P/FCF
-
Op. Cash Flow
-25.7K
FCF
-
Op. Margin
-368.40%
Net Margin
-377.60%
ROE
-59.50%
ROI
-53.70%
ROA
-43.80%
EPS Growth
-47.90%
Current Ratio
7.9
Debt/Equity
0.60%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Biostar Pharmaceuticals Inc (BSPM) $3.26 - - 8.6M Strong Buy
Daxor Corporation (DXR) $8.79 - 0.30% 34.4M Strong Buy
Dynatronics Corporation (DYNT) $2.55 - - 7.6M Strong Buy
Eleven Biotherapeutics Inc (EBIO) $2.22 - - 58.4M Strong Buy
American Renal Associates Hold (ARA) $22.57 - - 676.6M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More